发明申请
US20110171205A1 NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR
审中-公开
新型15571,2245,14266,2882,52871,8203和16852分子及其用途
- 专利标题： NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR
- 专利标题（中）： 新型15571,2245,14266,2882,52871,8203和16852分子及其用途
-
申请号： US13012890申请日： 2011-01-25
-
公开(公告)号： US20110171205A1公开(公告)日： 2011-07-14
- 发明人: Martin R. Hodge , Clare M. Lloyd , Nadine S. Weich , Jose M. Lora , David White , Maria A. Glucksmann , Keith E. Robison , Inmaculada Silos-Santiago , Andrew D.J. Goodearl , Rory A.J. Curtis
- 申请人： Martin R. Hodge , Clare M. Lloyd , Nadine S. Weich , Jose M. Lora , David White , Maria A. Glucksmann , Keith E. Robison , Inmaculada Silos-Santiago , Andrew D.J. Goodearl , Rory A.J. Curtis
- 申请人地址： US MA Cambridge
- 专利权人： Millennium Pharmaceuticals, Inc.
- 当前专利权人： Millennium Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Cambridge
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07H21/04 ; C12N5/00 ; C07K14/00 ; C07K16/18 ; C12P21/02 ; C12Q1/68 ; G01N33/53 ; A61K38/17 ; A61K31/7088 ; C12N15/11 ; C12N1/21 ; A61P25/00 ; A61P19/02 ; A61P25/28 ; A61P25/16 ; A61P25/18 ; A61P9/00 ; A61P9/04 ; A61P35/00 ; A61P3/10 ; A61P15/02
摘要：
The invention provides isolated nucleic acids molecules, designated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 15571, 2465, 14266, 2882, 52871, 8203 or 16852 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 15571, 2465, 14266, 2882, 52871, 8203 or 16852 gene has been introduced or disrupted. The invention still further provides isolated 15571, 2465, 14266, 2882, 52871, 8203 or 16852 proteins, fusion proteins, antigenic peptides and anti-15571, 2465, 14266, 2882, 52871, 8203 or 16852 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
信息查询
